Nigerian pharmaceutical company Fidson Healthcare plans to raise NGN6bn ($18.65m) through a rights offering of shares.

Sarepta Therapeutics has announced a public offering of 7.65 million shares of common stock priced at $42.5 a share to raise $325.13m.

The US-based biopharmaceutical company plans to use the funds towards clinical trials, business development, and general corporate purposes.

Chinese pharmaceutical company North China Pharmaceutical plans to raise CNY500m ($74.02m) through a private placement of bonds due 2021.